CytomX Therapeutics

Price & Volume

Stats

See more
52W Range
$1.72-$8.21
Market Cap
$828.3M
Shares Short
29M

Financials

See more
Revenue (12 Mos)
$35.5M
Revenue Growth (YoY)
-79.9%
Gross Profit (12 Mos)
$35.5M
Diluted EPS
-$0.52

About

CEO
Dr. Sean A. McCarthy DPHIL
CFO
Mr. Christopher W. Ogden
Address
151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
69